Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cairo conference and population issues

W M Moore

    Lancet (London, England)
    |October 8, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase.

    Bioorganic & medicinal chemistry letters·2001
    Same author

    A comparison of chronic combat-related posttraumatic stress disorder (PTSD) patients with and without a history of suicide attempt.

    The Journal of nervous and mental disease·2000
    Same author

    Attention to infants in the first year.

    Child: care, health and development·2000
    Same author

    All parents should be given leaflet outlining full details of antenatal screening.

    BMJ (Clinical research ed.)·1999
    Same author

    2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.

    Journal of medicinal chemistry·1998
    Same author

    2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).

    Journal of medicinal chemistry·1998
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    Same journal

    Dual mobility total hip replacement in fractures: stability promotes patient confidence.

    Lancet (London, England)·2026
    Same journal

    Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

    Lancet (London, England)·2026
    See all related articles